Author's posts
New Jersey medical office building sold
A 3,400-square-foot medical office building in Hamilton, N.J., has been sold by Fennelly Associates, according to a Feb. 22 report from roi-nj.com.
Florida physician to pay $190K to settle controlled substances violations
Pensacola, Fla.-based Timothy Ramsden, MD, has agreed to settle his alleged violation of the Controlled Substances Act with a $190,731 fine, the Justice Department said Feb. 22.
Amazon finalizes $3.9B One Medical acquisition: 4 things ASCs need to know
Amazon completed its $3.9 billion acquisition of primary care company One Medical.
The wealthiest US physician is worth $22.6B
Thomas Frist Jr., MD, co-founder and shareholder of Nashville, Tenn.-based HCA Healthcare, tops the list of billionaires in U.S. healthcare, according to the Bloomberg Billionaires Index as of Feb. 21.
Private equity demand to remain strong in orthopedics: report
Although the supply of orthopedic surgeons in the U.S. is low, the specialty remains attractive for private equity investors, according to a report in the Journal of Orthopaedic Experience & Innovation.
$5.6M paid for Colorado medical office building
A medical office building in Erie, Colo., was acquired by a private real estate company for $5.6 million, REBusiness Online reported Feb. 21.
1 paid malpractice claim makes a 2nd claim 4 times more likely: Study
A new JAMA study shows that physicians who have settled one medical malpractice claim are four times more likely than their peers to face additional claims in the future, according to a Feb. 22 report from Medscape.
580+ ASCs with total joint replacements | 2023
Here are 580+ ASCs wtih total joint replacements in 2023.
Why medical building developers are constructing in residential areas
A growing number of U.S. residents are interested in purchasing homes in densely packed communities near medical providers, according to a Feb. 22 report from REJournals.
How gastroenterologists feel about biosimilars
All gastroenterologists are at least somewhat comfortable prescribing biosimilars to their patients, according to Cardinal Health’s 2023 “Biosimilars Report,” which surveyed over 350 providers in four physician specialties.
